McKesson Corporation vs Slide Insurance Holdings Inc. Common Stock — how do they compare? McKesson Corporation trades at $986 (market cap $113.86B), while Slide Insurance Holdings Inc. Common Stock trades at $25.84 (market cap $3.00B). The key difference: McKesson Corporation is far larger — about 38× Slide Insurance Holdings Inc. Common Stock's market cap, and Slide Insurance Holdings Inc. Common Stock pays the higher dividend (1.09%). Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Slide Insurance Holdings Inc. Common Stock for 0 Days on average.
| MCK | SLDE | |
|---|---|---|
Market Cap | $113.86B | $3.00B |
Volume | 767,917 | 1,061,663 |
Sector | Health | Financials |
52-Week High | $995.69 | $26.48 |
52-Week Low | $725.17 | $14.38 |
Typical Hold Time | 74 Days | 0 Days |
Enterprise Value | $120.40B | $1.80B |
Dividend Yield | 0.39% | 1.09% |
Signals from Pluang's Aura AI — not financial advice
MCK trades at $961.88, up 0.64% today, showing strong momentum with three consecutive earnings beats and a bullish technical outlook. The stock benefits from robust revenue growth reaching $359.1B in 2025 and positive sentiment from the recent CVS Health partnership extension through 2032. Analyst consensus remains strongly bullish with 81% buy ratings and a $956.43 price target, though the current price slightly exceeds this target.
MCK presents a compelling investment case with solid fundamentals and growth trajectory, though investors should monitor margin pressures and competitive dynamics. The company's strong cash flow generation and institutional support provide stability, while technical indicators suggest near-term resistance around $967-$978 levels could limit immediate upside potential.
SLDE trades at $25.50, down slightly (-0.12%) on the day, with strong fundamental metrics including a P/E of 6.16 and net income margin of 40.02%. The company has consistently beaten earnings expectations in recent quarters, with Q3 2026 results scheduled for October 27, 2026. Revenue growth from $1.16B in 2025 to projected $1.4B in 2026 demonstrates solid business momentum, supported by expanded insurance offerings in key markets.
The stock presents attractive value with strong profitability and analyst support (80% buy ratings), though hurricane exposure in Florida remains a key risk. Current price sits near consensus target of $25.00, suggesting limited near-term upside but solid fundamentals for long-term investors. Management's share repurchase program and dividend initiation provide additional shareholder value support.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Slide Insurance Holdings, Inc. is a technology-enabled insurance company based in Florida that underwrites coastal specialty personal lines insurance, including homeowners and condominium unit owner policies, and also provides reinsurance and insurance agency services.
Read more on SLDE →